X4 Pharmaceuticals
IPO
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2014
- Business Model
- B2B
- Website
- x4pharma.com
- Total Funding
- $446.8M
- Last Round
- $155.3M Series COct 2025
About
Clinical-stage biopharmaceutical company developing novel, oral medicines designed to treat a range of rare diseases, including primary immunodeficiency diseases and rare cancers.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account